SSI Investment Management LLC Purchases New Position in iShares Biotechnology ETF $IBB

SSI Investment Management LLC purchased a new stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 36,104 shares of the financial services provider’s stock, valued at approximately $6,093,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Basepoint Wealth LLC bought a new stake in shares of iShares Biotechnology ETF during the fourth quarter valued at approximately $26,000. Cary Street Partners Financial LLC bought a new stake in shares of iShares Biotechnology ETF during the fourth quarter valued at approximately $29,000. Darwin Wealth Management LLC bought a new stake in shares of iShares Biotechnology ETF during the second quarter valued at approximately $25,000. Cornerstone Planning Group LLC bought a new stake in shares of iShares Biotechnology ETF during the fourth quarter valued at approximately $35,000. Finally, Copia Wealth Management bought a new stake in shares of iShares Biotechnology ETF during the fourth quarter valued at approximately $34,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of IBB opened at $172.18 on Friday. iShares Biotechnology ETF has a twelve month low of $120.33 and a twelve month high of $179.64. The firm has a 50 day moving average of $169.35 and a 200 day moving average of $170.34.

iShares Biotechnology ETF Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 20th. Shareholders of record on Tuesday, March 17th were given a $0.1218 dividend. This represents a $0.49 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date of this dividend was Tuesday, March 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.